In healthcare, compounding pharmacies stand as pillars of innovation and personalized care. Harnessing the power of customization, these specialized pharmacies play a crucial role in tailoring medications to meet the unique needs of individual patients. From addressing allergies and dosage preferences to creating specialized formulations unavailable in standard pharmaceuticals, compounding pharmacies offer a spectrum of solutions that traditional pharmacies cannot match.
The global compounding pharmacy market is poised to reach a valuation of USD 14.82 billion by 2030, at a CAGR of 6.2 percent during the forecast period of 2023 to 2030. This growth trajectory is propelled by the increasing rate of patent expirations, increased life expectancy, and the growing elderly population.
This edition of Healthcare Business Review presents a comprehensive overview of the latest developments in the compounding pharmacy sector, shedding light on evolving health strategies, innovations and wellness trends shaping the global landscape.
It features insightful articles from industry leaders Nick Capote, systemwide director of oncology, infusion and investigational drug pharmacy services at UCSF Health, and David Short, chief quality officer at QuVa Pharma.
Drawing upon his extensive expertise and experience as the health pharmacy director, Nick delves into crucial topics such as pharmaceutical care within an organization. David offers insights into the 503B facility and the intricate link between the pharmacy and the drug manufacturer.
This edition spotlights MixMyRx, which offers a favorable patient-centric approach in the pharmacy industry with an innovative business model.
We hope this edition of Top Compounding Pharmacy Services Providers 2024 helps you find the appropriate partner to guide you in your compounding pharmacy requirements.